Home > Research > Publications & Outputs > Enterprising or altruistic selves?
View graph of relations

Enterprising or altruistic selves?: making up research subjects in genetics research

Research output: Contribution to Journal/MagazineJournal articlepeer-review

Published

Standard

Enterprising or altruistic selves? making up research subjects in genetics research. / Tutton, Richard; Prainsack, Barbara.
In: Sociology of Health and Illness, Vol. 33, No. 7, 11.2011, p. 1081-1095.

Research output: Contribution to Journal/MagazineJournal articlepeer-review

Harvard

APA

Vancouver

Tutton R, Prainsack B. Enterprising or altruistic selves? making up research subjects in genetics research. Sociology of Health and Illness. 2011 Nov;33(7):1081-1095. doi: 10.1111/j.1467-9566.2011.01348.x

Author

Tutton, Richard ; Prainsack, Barbara. / Enterprising or altruistic selves? making up research subjects in genetics research. In: Sociology of Health and Illness. 2011 ; Vol. 33, No. 7. pp. 1081-1095.

Bibtex

@article{0e2786b97e6242d89231031cd43f4430,
title = "Enterprising or altruistic selves?: making up research subjects in genetics research",
abstract = "The emergence of direct-to-consumer (DTC) personal genomics companies in 2007 was accompanied by considerable media attention and criticism from clinical geneticists and other health professionals, regulators, policy advisors, and ethicists. As well as offering genetic testing services, some firms are also engaged in building their own databases and conducting research with the data obtained from their customers. In this paper, we examine how one of these companies, 23andMe, is creating a certain kind of 'research subject' in opposition to that constituted in conventional forms of disease research. Drawing on debates about neoliberalism, contemporary health discourses and subjectivity, we consider two kinds of subjectivities produced through the discursive and material practices of 23andMe and UK Biobank, namely, 'enterprising' and 'altruistic' selves. We argue that the 23andMe model promotes the idea that curiosity about one's genome on the one hand, and participation in research on the other, are not only compatible but complementary aspects of being an entrepreneurial subject of contemporary health and medicine framed by the technologies of web 2.0.",
keywords = "research participation, personal genomics , subjectivity , internet , biobanking",
author = "Richard Tutton and Barbara Prainsack",
note = "{\textcopyright} 2011 The Authors. Sociology of Health & Illness {\textcopyright} 2011 Foundation for the Sociology of Health & Illness/Blackwell Publishing Ltd.",
year = "2011",
month = nov,
doi = "10.1111/j.1467-9566.2011.01348.x",
language = "English",
volume = "33",
pages = "1081--1095",
journal = "Sociology of Health and Illness",
issn = "0141-9889",
publisher = "Blackwell Publishing Ltd",
number = "7",

}

RIS

TY - JOUR

T1 - Enterprising or altruistic selves?

T2 - making up research subjects in genetics research

AU - Tutton, Richard

AU - Prainsack, Barbara

N1 - © 2011 The Authors. Sociology of Health & Illness © 2011 Foundation for the Sociology of Health & Illness/Blackwell Publishing Ltd.

PY - 2011/11

Y1 - 2011/11

N2 - The emergence of direct-to-consumer (DTC) personal genomics companies in 2007 was accompanied by considerable media attention and criticism from clinical geneticists and other health professionals, regulators, policy advisors, and ethicists. As well as offering genetic testing services, some firms are also engaged in building their own databases and conducting research with the data obtained from their customers. In this paper, we examine how one of these companies, 23andMe, is creating a certain kind of 'research subject' in opposition to that constituted in conventional forms of disease research. Drawing on debates about neoliberalism, contemporary health discourses and subjectivity, we consider two kinds of subjectivities produced through the discursive and material practices of 23andMe and UK Biobank, namely, 'enterprising' and 'altruistic' selves. We argue that the 23andMe model promotes the idea that curiosity about one's genome on the one hand, and participation in research on the other, are not only compatible but complementary aspects of being an entrepreneurial subject of contemporary health and medicine framed by the technologies of web 2.0.

AB - The emergence of direct-to-consumer (DTC) personal genomics companies in 2007 was accompanied by considerable media attention and criticism from clinical geneticists and other health professionals, regulators, policy advisors, and ethicists. As well as offering genetic testing services, some firms are also engaged in building their own databases and conducting research with the data obtained from their customers. In this paper, we examine how one of these companies, 23andMe, is creating a certain kind of 'research subject' in opposition to that constituted in conventional forms of disease research. Drawing on debates about neoliberalism, contemporary health discourses and subjectivity, we consider two kinds of subjectivities produced through the discursive and material practices of 23andMe and UK Biobank, namely, 'enterprising' and 'altruistic' selves. We argue that the 23andMe model promotes the idea that curiosity about one's genome on the one hand, and participation in research on the other, are not only compatible but complementary aspects of being an entrepreneurial subject of contemporary health and medicine framed by the technologies of web 2.0.

KW - research participation

KW - personal genomics

KW - subjectivity

KW - internet

KW - biobanking

U2 - 10.1111/j.1467-9566.2011.01348.x

DO - 10.1111/j.1467-9566.2011.01348.x

M3 - Journal article

C2 - 21507012

VL - 33

SP - 1081

EP - 1095

JO - Sociology of Health and Illness

JF - Sociology of Health and Illness

SN - 0141-9889

IS - 7

ER -